Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Antibióticos orales versus inhalados para la bronquiectasia

Información

DOI:
https://doi.org/10.1002/14651858.CD012579.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 27 marzo 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Sally Spencer

    Correspondencia a: Postgraduate Medical Institute, Edge Hill University, Ormskirk, UK

    [email protected]

  • Lambert M Felix

    Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK

  • Stephen J Milan

    Medical School, Lancaster University, Lancaster, UK

  • Rebecca Normansell

    Cochrane Airways, Population Health Research Institute, St George's, University of London, London, UK

  • Pieter C Goeminne

    AZ Nikolaas, Sint‐Niklaas, Belgium

    UZ Leuven, Leuven, Belgium

  • James D Chalmers

    University of Dundee, Ninewells Hospital and Medical School, Dundee, UK

  • Tim Donovan

    Medical and Sport Sciences, University of Cumbria, Lancaster, UK

Contributions of authors

PG and LF independently screened the search in consultation with SS, SJM and JDC. LF, SS and SJM completed the analyses and Results section. All review authors contributed to the Discussion, Conclusions and remaining sections of the review.

Sources of support

Internal sources

  • Edge Hill University, UK.

    Provided funding for a part‐time review author (LF) to support a series of Cochrane Reviews on bronchiectasis.

External sources

  • All authors, UK.

    This review was completed, in part, through a grant of £5,000 from the Cochrane Review Support Programme.

Declarations of interest

SS: is the lead applicant on a grant from Edge Hill University that provides support staff for a number of bronchiectasis reviews. She is also an editor with the Cochrane Airways Group.

LF: none known

SM: none known

RN: is Joint Co‐ordinating Editor with the Cochrane Airways Group.

PCG: has received lecture fees from Novartis, Chiesi, Eurogenerics, Astra Zeneca and Boehringer and received travel accommodation from Chiesi and Novartis.

JDC: has received research funding from Astrazeneca and Pfizer, and has received lecture fees or served on advisory boards for Bayer, Griffols, Astrazeneca, Pfizer, Napp and Chiesi.

Acknowledgements

We thank Edge Hill University and Lancaster University for their support in the development of this review. Dr Chalmers and Dr Goeminne acknowledge support from the European Bronchiectasis Network (EMBARC), which is funded by the European Respiratory Society.

We would also like to thank the Cochrane Airways Group for their support.

The Background and Methods sections of this protocol are based on a standard template used by Cochrane Airways.

This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service, or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2018 Mar 27

Oral versus inhaled antibiotics for bronchiectasis

Review

Sally Spencer, Lambert M Felix, Stephen J Milan, Rebecca Normansell, Pieter C Goeminne, James D Chalmers, Tim Donovan

https://doi.org/10.1002/14651858.CD012579.pub2

2017 Mar 05

Oral versus inhaled antibiotics for non‐cystic fibrosis bronchiectasis

Protocol

Sally Spencer, Lambert M Felix, Stephen J Milan, Rebecca Normansell, Pieter C Goeminne, James D Chalmers

https://doi.org/10.1002/14651858.CD012579

Differences between protocol and review

As there are multiple manufacturers of both oral and inhaled antibiotics and many are off‐patent, we did not conduct a search of manufacturers websites.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Adult; Child; Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Ir a la figura de la revisiónAbrir en una pestaña nueva